Table 2.

Comparison of participants’ urinary phthalate metabolite concentrations (ng/mL) to concentrations detected in the general population (based on NHANES data from 2003–2004).

Subject#	MBP	MCPP	MBzP	MEHP	MEOHP	MEHHP	MECPP	MEP	MiBP
Population Geometric Mean**	21.1	2.91	13.7	2.34	14.5	21.7	34.7	193	3.8
Population 95%ile**	122	15.3	101	31	157	266	339	2700	21.3
Participant 1	9888	116	1.1	<LOD	12.1	20.9	39.4	36.2	19.3
Participant 2	17.5	5.8	14.8	3.4	28.3	52.8	92.7	2739	7
Participant 3	12308	163	19	5	35.5	64.4	92.7	300	30.7
Participant 4	10124	72.6	9.3	4.8	35	61.1	90.3	412	21.1
Participant 5	41590	560	10.8	10.6	34.4	59.2	67.2	350	59.3

Abbreviations: MBP = Mono-n-butyl phthalate; MBzP = Monobenzyl phthalate; MCPP = Mono-3-carboxypropyl phthalate; MECPP = Mono-2-ethyl-5-carboxypentyl phthalate; MEHHP = Mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP = Mono-2-ethylhexyl phthalate; MEOHP = Mono-2-ethyl-5-oxohexyl phthalate; MEP = Monoethyl phthalate; MiBP = Mono-isobutyl phthalate LOD = limit of detection. LOD (in ng/mL): mECPP = 0.25; mEHHP = 0.32; MEOHP = 0.45; mEHP = 0.9; mCPP = 0.16; miBP = 0.26; mBP = 0.4; mBzP = 0.11; mEP = 0.4;

^**www.cdc.gov/exposurereport (NHANES 2003–2004) - accessed 05/10/10